Global Health & Policy

Global Health & Policy examines the broader systems, infrastructure, equity frameworks, and public health strategies that shape pediatric neurological care worldwide. Neurological disorders contribute significantly to childhood disability-adjusted life years, particularly in low- and middle-income regions where access to diagnostic tools, specialist care, and advanced therapies may be limited. Discussions within every major Pediatric Neurology Conference increasingly focus on building sustainable, equitable models of care delivery across diverse healthcare systems.

The burden of pediatric neurological disorders—including epilepsy, cerebral palsy, neuroinfections, stroke, neurodevelopmental conditions, and rare genetic diseases—varies widely by geography and socioeconomic context. Closely aligned with Global Pediatric Neurology Policy, this field integrates public health, epidemiology, health economics, regulatory governance, and clinical medicine to strengthen service accessibility and long-term outcomes. National newborn screening programs, vaccination policies, neurocritical care infrastructure, and rehabilitation networks significantly influence population-level neurological health.

Workforce shortages remain a major barrier in many regions. Training programs, tele-neurology initiatives, and cross-border knowledge exchange are essential to expand specialist capacity. Policy frameworks must address reimbursement models, access to essential antiseizure medications, availability of neuroimaging, and inclusion of rehabilitation services in universal health coverage plans.

Data-driven policy development is increasingly emphasized. National registries, epidemiologic surveillance systems, and burden-of-disease modeling inform resource allocation and preventive strategies. Early screening and community-based intervention programs reduce long-term disability costs and improve societal participation.

Equity remains central to global pediatric neurology. Socioeconomic disparities, rural–urban gaps, and limited insurance coverage can delay diagnosis and restrict therapy access. Advocacy initiatives and international partnerships help bridge these gaps through collaborative research, funding mechanisms, and capacity-building projects.

Ethical considerations include fair distribution of high-cost therapies such as gene treatments, inclusive representation in clinical trials, and culturally sensitive care delivery models. Sustainable health systems require collaboration between clinicians, policymakers, researchers, and community leaders.

By integrating epidemiologic evidence, workforce development strategies, equitable financing models, and global partnerships, pediatric neurology policy initiatives can significantly reduce preventable neurological disability and strengthen child health outcomes worldwide.